Active	Status	Sponsor type	Region	Phase	Filter
2 Active 6 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
levodopa/carbidopa orally disintegrating tablets / Generic mfg.
NCT05087914: Novel Non-opioid Post-surgical Pain Treatment in Females	Withdrawn	2	60	US	Carbidopa-Levodopa (100mg/25mg):, Sinemet, Parcopa, Rytary, Naproxen, Aleve, Anaprox, Naprosyn, Naprelan, Menstridol	Northwestern University, Northwestern Medical Group, National Institutes of Health (NIH)	Acute Pain, Bunionectomy, Toe Fusion	12/23	01/24
NCT04821830: Vigor and the LDR in Parkinson Disease	Completed	N/A	19	US	carbidopa/levodopa, as prescribed by treating physician, Parcopa, Sinemet	University of Michigan, National Institute of Neurological Disorders and Stroke (NINDS)	Parkinson Disease	04/24	04/24